20 May 2013
Keywords: astrazeneca, crestor, leads, way, meeting, new, european
Article | 05 April 2004
New data published in the European Heart Journal reveals that AstraZeneca's Crestor (rosuvastatin) enables significantly more patients
to achieve the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 April 2004
17 May 2013
© 2013 thepharmaletter.com